|
|||||
JenamicinActive Ingredient(s): GentamicinPossible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to JenamicinCream 0.1% Injection 0.1mg/ml, 0.6mg/ml, 0.8mg/ml, 0.9mg/ml, 1.2mg/ml, 1.4mg/ml, 1.6mg/ml, 100mg/100ml, 10mg/ml, 1mg/ml, 2mg/ml, 40mg/ml Ointment 0.1%, 0.3%, 3mg/g Solution 0.3%, 3mg/ml Solution/drops 0.3% Related Drug Page(s):Other Drugs Containing Gentamicin or a Similar Compund: Related Search Results for JenamicinWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Jenamicin Text Link HTML Code: Related: Jenamicin history, Jenamicin precautions side effects, Jenamicin pdr technical class biotech classification, types precautions Jenamicin, Jenamicin title history, biotech Jenamicin, ingredients types Jenamicin, Jenamicin instructions lookup pharmacology value, material headline Jenamicin, policy classification details forums company Jenamicin. Gentamicin pharma pharma warnings effect guidelines, studies alternative Gentamicin, Gentamicin plan manufacturer company, Gentamicin dictionary feedback, Gentamicin educate name, Gentamicin contraindications alert online class pertinent. Return to Top Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2009 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Jenamicin.asp Last Updated June 27 2005 |
|||||